| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.092 | 0.3 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.17 | 0.3 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.22 | 0.3 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |